| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Apr 15, 2015 | Apr 17, 2015 | Plattner Jacob J SVP Research | Sell | $62.81 | $560,265 | -21.92% |
| Apr 01, 2015 | Apr 03, 2015 | Maples Kirk R SVP Program Management | Sell | $57.02 | $34,209 | -6.65% |
| Mar 23, 2015 | Mar 23, 2015 | Parker Geoffrey M. EVP CFO | Buy | $52.43 | $157,304 | +1.07% |
| Mar 19, 2015 | Mar 23, 2015 | Berns Paul L Pres CEO | Sell | $56.07 | $2M | -10.83% |
| Mar 16, 2015 | Mar 18, 2015 | Plattner Jacob J SVP Research | Sell | $55.6 | $495,952 | -17.98% |
| Mar 16, 2015 | Mar 18, 2015 | Zane Lee SVP Chief Medical Officer | Sell | $56.44 | $677,225 | -29.88% |
| Mar 04, 2015 | Mar 05, 2015 | Chanda Sanjay SVP Drug Development | Sell | $45 | $225,000 | -14.67% |
| Mar 03, 2015 | Mar 05, 2015 | Ippolito Vincent P EVP Chief Commercial Officer | Sell | $43.88 | $394,937 | -11.31% |
| Mar 02, 2015 | Mar 05, 2015 | Plattner Jacob J SVP Research | Sell | $44.02 | $302,656 | -12.17% |
| Mar 02, 2015 | Mar 05, 2015 | Maples Kirk R SVP Program Management | Sell | $43.95 | $26,369 | -6.24% |
| Feb 02, 2015 | Feb 04, 2015 | Maples Kirk R SVP Program Management | Sell | $37.41 | $22,448 | -11.54% |
| Feb 02, 2015 | Feb 04, 2015 | Plattner Jacob J SVP Research | Sell | $37.35 | $256,781 | -11.78% |
| Jan 02, 2015 | Jan 06, 2015 | Plattner Jacob J SVP Research | Sell | $32.09 | $220,619 | -10.54% |
| Jan 02, 2015 | Jan 06, 2015 | Maples Kirk R SVP Program Management | Sell | $31.96 | $19,174 | -12.50% |
| Dec 26, 2014 | Dec 29, 2014 | Berns Paul L Pres CEO | Sell | $30.82 | $770,505 | -7.14% |
| Dec 10, 2014 | Dec 12, 2014 | Shapiro Lucy Dir | Sell | $35.11 | $10M | -91.19% |
| Dec 10, 2014 | Dec 12, 2014 | Zane Lee SVP Chief Medical Officer | Sell | $36.09 | $176,851 | -41.18% |
| Dec 09, 2014 | Dec 11, 2014 | Maples Kirk R SVP Program Management | Sell | $36.52 | $2M | -92.59% |
| Dec 01, 2014 | Dec 04, 2014 | Plattner Jacob J SVP Research | Sell | $33.34 | $229,237 | -9.54% |
| Dec 01, 2014 | Dec 04, 2014 | Maples Kirk R SVP Program Management | Sell | $33.38 | $20,026 | -11.11% |
| Nov 26, 2014 | Dec 02, 2014 | Chanda Sanjay SVP Drug Development | Sell | $35 | $175,000 | -55.59% |
| Nov 03, 2014 | Nov 05, 2014 | Maples Kirk R SVP Program Management | Sell | $29.1 | $17,457 | -10.00% |
| Nov 03, 2014 | Nov 05, 2014 | Plattner Jacob J SVP Research | Sell | $29.32 | $201,563 | -8.71% |
| Oct 01, 2014 | Oct 02, 2014 | Maples Kirk R SVP Program Management | Sell | $23.85 | $14,312 | -9.09% |
| Oct 01, 2014 | Oct 02, 2014 | Plattner Jacob J SVP Research | Sell | $24.47 | $168,231 | -8.01% |
| Sep 26, 2014 | Sep 30, 2014 | Hove Anders D Dir | Sell | $25 | $500,000 | -0.73% |
| Sep 18, 2014 | Sep 22, 2014 | Hove Anders D Dir | Sell | $24.87 | $18M | -21.23% |
| Sep 12, 2014 | Sep 16, 2014 | Hove Anders D Dir | Sell | $24.99 | $2M | -2.52% |
| Sep 10, 2014 | Sep 12, 2014 | Chanda Sanjay SVP Drug Development | Sell | $24.25 | $242,500 | -71.45% |
| Sep 05, 2014 | Sep 08, 2014 | Parker Geoffrey M. EVP CFO | Buy | $21.82 | $143,807 | +2.41% |